Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
H-Index
3
Total Works
273
Total Citations
66
2yr Mean Citedness
0.16
Free JIF alternative
Aims & Scope✦ Inferred from recent articles
The journal focuses on the diagnosis, treatment, and clinical manifestations of infectious and parasitic diseases in humans. It covers viral infections such as Mpox, COVID-19, measles, and respiratory syncytial virus, as well as bacterial infections like sepsis and tonsillitis. The scope also includes parasitic infections like toxoplasmosis and cystoisosporiasis, and fungal infections. Research areas encompass antimicrobial resistance, the impact of infections on specific patient groups (e.g., children, immunocompromised individuals), and the development of diagnostic and prognostic models.
AI-summarised from recent articles · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
EpidemiologyUnranked
HepatologyUnranked
Infectious DiseasesUnranked
ParasitologyUnranked
Pulmonary and Respiratory MedicineUnranked
VirologyUnranked
Subject Classification
Scopus Categories
VirologyPulmonary and Respiratory MedicineHepatologyInfectious DiseasesEpidemiologyParasitology
Research Topics (OpenAlex)
COVID-19 Clinical Research StudiesHepatitis C virus researchPediatric health and respiratory diseasesTuberculosis Research and EpidemiologyLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchHepatitis B Virus StudiesRespiratory viral infections researchStreptococcal Infections and TreatmentsClostridium difficile and Clostridium perfringens research